These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 15563864)
1. Management of neuroendocrine differentiated breast carcinoma. Berruti A; Saini A; Leonardo E; Cappia S; Borasio P; Dogliotti L Breast; 2004 Dec; 13(6):527-9. PubMed ID: 15563864 [TBL] [Abstract][Full Text] [Related]
2. Postoperative recurrence and the role of adjuvant chemotherapy in patients with pulmonary large-cell neuroendocrine carcinoma. Iyoda A; Hiroshima K; Moriya Y; Iwadate Y; Takiguchi Y; Uno T; Nakatani Y; Yoshino I J Thorac Cardiovasc Surg; 2009 Aug; 138(2):446-53. PubMed ID: 19619794 [TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine carcinomas of the breast. Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937 [TBL] [Abstract][Full Text] [Related]
4. Well-differentiated neurotensin-producing neuroendocrine carcinoma of the breast. Report of a case. La Rosa S; Usellini L; Riva C; Capella C Histopathology; 2007 Dec; 51(6):846-7. PubMed ID: 17894802 [No Abstract] [Full Text] [Related]
5. Solid neuroendocrine carcinoma of the breast. Abbasi NZ; Zahur Z; Sheikh AS; Khan AA; Ali F; Memon KH; Moizuddin SS; Loya A; Barkat N J Coll Physicians Surg Pak; 2013 Nov; 23(10):820-2. PubMed ID: 24169396 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial of paclitaxel, carboplatin, and etoposide in advanced poorly differentiated neuroendocrine carcinoma: a Minnie Pearl Cancer Research Network Study. Hainsworth JD; Spigel DR; Litchy S; Greco FA J Clin Oncol; 2006 Aug; 24(22):3548-54. PubMed ID: 16877720 [TBL] [Abstract][Full Text] [Related]
7. Large cell neuroendocrine carcinoma of the lung: a retrospective analysis of 144 surgical cases. Veronesi G; Morandi U; Alloisio M; Terzi A; Cardillo G; Filosso P; Rea F; Facciolo F; Pelosi G; Gandini S; CalabrĂ² F; Casali C; Marulli G; Spaggiari L Lung Cancer; 2006 Jul; 53(1):111-5. PubMed ID: 16697073 [TBL] [Abstract][Full Text] [Related]
8. [Treatment strategy for neuroendocrine carcinoma of the lung]. Kawase A; Nagai K Gan To Kagaku Ryoho; 2009 Oct; 36(10):1619-22. PubMed ID: 19838019 [TBL] [Abstract][Full Text] [Related]
9. Primary neuroendocrine carcinoma of the breast, which chemotherapy? El Hassani LK; Bensouda Y; M'Rabti H; Boutayeb S; Kamouni M; Gamra L; Errihani H Indian J Cancer; 2009; 46(4):352-4. PubMed ID: 19749475 [No Abstract] [Full Text] [Related]
10. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues. Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194 [TBL] [Abstract][Full Text] [Related]
11. Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. Berruti A; Mosca A; Tucci M; Terrone C; Torta M; Tarabuzzi R; Russo L; Cracco C; Bollito E; Scarpa RM; Angeli A; Dogliotti L Endocr Relat Cancer; 2005 Mar; 12(1):109-17. PubMed ID: 15788643 [TBL] [Abstract][Full Text] [Related]
12. Fine needle aspiration cytology of neuroendocrine carcinoma of the breast--a case report and review of literature. Kadir AA; Iyengar KR; Peh SC; Yip CH Malays J Pathol; 2008 Jun; 30(1):57-61. PubMed ID: 19108413 [TBL] [Abstract][Full Text] [Related]
13. Moderately differentiated neuroendocrine carcinoma (atypical carcinoid) of the larynx: a clinically aggressive tumor. Gillenwater A; Lewin J; Roberts D; El-Naggar A Laryngoscope; 2005 Jul; 115(7):1191-5. PubMed ID: 15995505 [TBL] [Abstract][Full Text] [Related]
14. Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy. Er O; Frye DK; Kau SW; Broglio K; Valero V; Hortobagyi GN; Arun B Cancer J; 2008; 14(1):62-8. PubMed ID: 18303485 [TBL] [Abstract][Full Text] [Related]
15. A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast. Okoshi K; Saiga T; Hisamori S; Iwaisako K; Kobayashi H; Ogawa H Breast Cancer; 2012 Oct; 19(4):360-4. PubMed ID: 19669861 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16. Crump M; Gluck S; Tu D; Stewart D; Levine M; Kirkbride P; Dancey J; O'Reilly S; Shore T; Couban S; Girouard C; Marlin S; Shepherd L; Pritchard KI J Clin Oncol; 2008 Jan; 26(1):37-43. PubMed ID: 18025439 [TBL] [Abstract][Full Text] [Related]
17. Large cell neuroendocrine carcinoma of the lung: what we have to do. Filosso PL J Thorac Cardiovasc Surg; 2003 May; 125(5):1182-3; author reply 1183-4. PubMed ID: 12771909 [No Abstract] [Full Text] [Related]
18. Metastatic neuroendocrine carcinomas to the head and neck: report of 4 cases and review of the literature. Salama AR; Jham BC; Papadimitriou JC; Scheper MA Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):242-7. PubMed ID: 19615663 [TBL] [Abstract][Full Text] [Related]
19. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases. Veras E; Deavers MT; Silva EG; Malpica A Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463 [TBL] [Abstract][Full Text] [Related]
20. Prospective study of adjuvant chemotherapy for pulmonary large cell neuroendocrine carcinoma. Iyoda A; Hiroshima K; Moriya Y; Takiguchi Y; Sekine Y; Shibuya K; Iizasa T; Kimura H; Nakatani Y; Fujisawa T Ann Thorac Surg; 2006 Nov; 82(5):1802-7. PubMed ID: 17062251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]